glp-1 agonists examples Diabetes Patients Also Struggle to Access GLP-1 Agonists - What is
Description
doi: 10.2337/diab.45.6.832 [DOI] [PubMed] [Google Scholar] 144
Most available GLP-1 RAs are given as subcutaneous injections
It is worth mentioning that most of the reasons could be demystified with proper diabetes education and with the new, easier-to-use and painless devices to deliver insulin and monitor blood glucose
"Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine
Most are injectable medications, although one oral formulation is currently available
However, all studies were performed on stage 3 type 1 diabetes, so whether initiation of these drugs at earlier stages of the disease can help prevent cell function loss is unknown
